Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 29, Issue 6, 2016, Pages 627-633

  Harada, K ^a   Ida, S ^a,b   Baba, Y ^a   Ishimoto, T ^a   Kosumi, K ^a   Tokunaga, R ^a   Izumi, D ^a   Ohuchi, M ^a   Nakamura, K ^a   Kiyozumi, Y ^a   Imamura, Y ^a   Iwatsuki, M ^a   Iwagami, S ^a   Miyamoto, Y ^a   Sakamoto, Y ^a   Yoshida, N ^a   Watanabe, M ^b   Baba, H ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

esophageal squamous cell carcinoma (ESCC); nutrition; prognostic factor; sarcopenia

Indexed keywords

AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; JAPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE; THORACOSCOPY; THORACOTOMY; TREATMENT OUTCOME;

EID: 84983539713     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12381     Document Type: Article

References (32)

1. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241–2252.
2. Allum W H, Stenning S P, Bancewicz J, Clark P I, Langley R E. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062–5067.
3. Gertler R, Stein H J, Langer R et al. Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system. Ann Surg 2011; 253: 689–698.
4. Pichard C, Kyle U G. Body composition measurements during wasting diseases. Curr Opin Clin Nutr Metab Care 1998; 1: 357–361.
5. Evans W J. What is sarcopenia? J Gerontol A Biol Sci Med Sci 1995; 50: 5–8.
6. Janssen I, Heymsfield S B, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889–896.
7. Baumgartner R N, Koehler K M, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755–763.
8. Landi F, Liperoti R, Fusco D et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012; 13: 121–126.
9. Muscaritoli M, Anker S D, Argiles J et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) ‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition in geriatrics’. Clin Nutr 2010; 29: 154–159.
10. Maltoni M, Caraceni A, Brunelli C et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations – a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005; 23: 6240–6248.
11. Evans W J, Morley J E, Argiles J et al. Cachexia: a new definition. Clin Nutr 2008; 27: 793–799.
12. Tan B H, Birdsell L A, Martin L, Baracos V E, Fearon K C. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973–6979.
13. van Vledder M G, Levolger S, Ayez N, Verhoef C, Tran T C, Ijzermans J N. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99: 550–557.
14. Sabel M S, Lee J, Cai S, Englesbe M J, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 2011; 18: 3579–3585.
15. Villasenor A, Ballard-Barbash R, Baumgartner K et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv 2012; 6: 398–406.
16. Harimoto N, Shirabe K, Yamashita Y I et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100: 1523–1530.
17. Sobin L H, Gospodarowicz M K, Wittekind C. International Union Against Cancer. TNM Classification of Malignant Tumours, 7th edn. Chichester, West Sussex, UK; Hoboken, NJ: Wiley–Blackwell, 2010.
18. McShane L M, Altman D G, Sauerbrei W, Taube S E, Gion M, Clark G M. REporting recommendations for tumor MARKer prognostic studies (REMARK). J Natl Cancer Inst 2005; 97: 1180–1184.
19. Mourtzakis M, Prado C M, Lieffers J R, Reiman T, McCargar L J, Baracos V E. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997–1006.
20. Prado C M, Lieffers J R, McCargar L J et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629–635.
21. Mitsiopoulos N, Baumgartner R N, Heymsfield S B, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115–122.
22. Shen W, Punyanitya M, Wang Z et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 2004; 97: 2333–2338.
23. Martin L, Birdsell L, Macdonald N et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539–1547.
24. Ando N, Kato H, Igaki H et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 2012; 19: 68–74.
25. Tan L J, Liu S L, Lei S F, Papasian C J, Deng H W. Molecular genetic studies of gene identification for sarcopenia. Hum Genet 2012; 131: 1–31.
26. Dodson S, Baracos V E, Jatoi A et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011; 62: 265–279.
27. Richards C H, Roxburgh C S, MacMillan M T et al. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS ONE 2012; 7: e41883.
28. Mariette C, Taillier G, Van Seuningen I, Triboulet J P. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 2004; 78: 1177–1183.
29. Stein H J, Feith M, Bruecher B L, Naehrig J, Sarbia M, Siewert J R. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005; 242: 566–575.
30. Choudhuri A H, Uppal R, Kumar M. Influence of non-surgical risk factors on anastomotic leakage after major gastrointestinal surgery: audit from a tertiary care teaching institute. Int J Crit Illn Inj Sci 2013; 3: 246–249.
31. Lieffers J R, Bathe O F, Fassbender K, Winget M, Baracos V E. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931–936.
32. Kabata P, Jastrzebski T, Kakol M et al. Preoperative nutritional support in cancer patients with no clinical signs of malnutrition-prospective randomized controlled trial. Support Care Cancer 2014; 23: 365–370.